Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Cancer-associated mesothelial cell–derived ANGPTL4 and STC1 promote the early steps of ovarian cancer metastasis
Preety Bajwa, Kasjusz Kordylewicz, Agnes Bilecz, Ricardo R. Lastra, Kristen Wroblewski, Yuval Rinkevich, Ernst Lengyel, Hilary A. Kenny
Preety Bajwa, Kasjusz Kordylewicz, Agnes Bilecz, Ricardo R. Lastra, Kristen Wroblewski, Yuval Rinkevich, Ernst Lengyel, Hilary A. Kenny
View: Text | PDF
Research Article Cell biology Oncology

Cancer-associated mesothelial cell–derived ANGPTL4 and STC1 promote the early steps of ovarian cancer metastasis

  • Text
  • PDF
Abstract

Ovarian cancer (OvCa) preferentially metastasizes in association with mesothelial cell–lined surfaces. We sought to determine if mesothelial cells are required for OvCa metastasis and detect alterations in mesothelial cell gene expression and cytokine secretion upon interaction with OvCa cells. Using omental samples from patients with high-grade serous OvCa and mouse models with Wt1-driven GFP-expressing mesothelial cells, we validated the intratumoral localization of mesothelial cells during human and mouse OvCa omental metastasis. Removing mesothelial cells ex vivo from human and mouse omenta or in vivo using diphtheria toxin-mediated ablation in Msln-Cre mice significantly inhibited OvCa cell adhesion and colonization. Human ascites induced angiopoietin-like 4 (ANGPTL4) and stanniocalcin 1 (STC1) expression and secretion by mesothelial cells. Inhibition of STC1 or ANGPTL4 via RNAi obstructed OvCa cell-induced mesothelial cell to mesenchymal transition while inhibition of ANGPTL4 alone obstructed OvCa cell-induced mesothelial cell migration and glycolysis. Inhibition of mesothelial cell ANGPTL4 secretion via RNAi prevented mesothelial cell–induced monocyte migration, endothelial cell vessel formation, and OvCa cell adhesion, migration, and proliferation. In contrast, inhibition of mesothelial cell STC1 secretion via RNAi prevented mesothelial cell–induced endothelial cell vessel formation and OvCa cell adhesion, migration, proliferation, and invasion. Additionally, blocking ANPTL4 function with Abs reduced the ex vivo colonization of 3 different OvCa cell lines on human omental tissue explants and in vivo colonization of ID8p53–/–Brca2–/– cells on mouse omenta. These findings indicate that mesothelial cells are important to the initial stages of OvCa metastasis and that the crosstalk between mesothelial cells and the tumor microenvironment promotes OvCa metastasis through the secretion of ANGPTL4.

Authors

Preety Bajwa, Kasjusz Kordylewicz, Agnes Bilecz, Ricardo R. Lastra, Kristen Wroblewski, Yuval Rinkevich, Ernst Lengyel, Hilary A. Kenny

×

Figure 5

Mesothelial cell–derived ANGTPLT4 and STC1 regulate endothelial cell, monocyte, and OvCa cell function.

Options: View larger image (or click on image) Download as PowerPoint
Mesothelial cell–derived ANGTPLT4 and STC1 regulate endothelial cell, mo...
Mesothelial cells were transfected with control, ANGPTL4, or STC1 siRNA followed by treatment with ascites (ASC) or control media. Subsequently, mesothelial cell CM was collected. (A) HUVECs were plated on Geltrex Matrix and treated with mesothelial cell CM. Tube formation was quantified using Calcein AM staining. Images of HUVECs and corresponding quantification. Scale bar: 300 μm. (B–E) Functional assays were performed using fluorescently labeled Tyk-Nu OvCa cells. OvCa cell adhesion (1 hour) was tested on top of the transfected and pretreated mesothelial cell monolayer in B. OvCa cell migration (12–24 hours) was tested using a Boyden chamber lined with transfected mesothelial cells in C. OvCa cell proliferation (72 hours) was tested on top of the transfected and pretreated mesothelial cell monolayer in D. OvCa cell invasion (24–48 hours) was tested through transfected and pretreated mesothelial cell monolayer and rat tail collagen type I using a Boyden chamber in E. (F) Human CD14+ cells were isolated from peripheral blood and placed in serum-free media in the top well of a 5 μm pore-size transwell. Mesothelial cell CM were placed in the bottom chamber and the number of cells migrated to the bottom well were recovered and counted after 4 hours. All data are shown as the mean ± SEM (n = 5–8). *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 calculated by 1-way ANOVA.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts